Sponsor:
CRISPR Therapeutics
Code:
NCT06925542
Conditions
SLE (Systemic Lupus)
Lupus Erythematosus, Systemic
Lupus Nephritis
Systemic Sclerosis
Inflammatory Myopathy, Idiopathic
Eligibility Criteria
Sex: All
Age: 18 - 70
Healthy Volunteers: Not accepted
Interventions
CTX112
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-12-14. This information was provided to ClinicalTrials.gov by CRISPR Therapeutics on 2025-10-10.